Jones Financial Companies Lllp Has $4.97 Million Stock Position in AMETEK, Inc. $AME

Key Points

• Jones Financial Companies Lllp has reduced its stake in AMETEK, Inc. by 59.3%, holding 28,841 shares valued at approximately $4.97 million at the end of the latest reporting period.
• AMETEK's stock has been upgraded by various analysts, with price targets ranging from $180.00 to $225.00, indicating a consensus rating of "Moderate Buy".
• The company recently announced a quarterly dividend of $0.31 per share, scheduled for payment on September 30th, representing an annualized yield of 0.7%.

Jones Financial Companies Lllp lessened its stake in AMETEK, Inc. (NYSE:AME - Free Report) by 59.3% in the 1st quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 28,841 shares of the technology company's stock after selling 42,015 shares during the quarter. Jones Financial Companies Lllp's holdings in AMETEK were worth $4,965,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Bares Capital Management Inc. acquired a new position in AMETEK in the 1st quarter worth $26,000. Olde Wealth Management LLC acquired a new position in shares of AMETEK during the first quarter worth about $29,000. Annis Gardner Whiting Capital Advisors LLC grew its holdings in shares of AMETEK by 57.7% during the first quarter. Annis Gardner Whiting Capital Advisors LLC now owns 194 shares of the technology company's stock worth $33,000 after buying an additional 71 shares in the last quarter. Zions Bancorporation National Association UT acquired a new stake in AMETEK in the 1st quarter valued at approximately $42,000. Finally, Minot DeBlois Advisors LLC acquired a new stake in AMETEK in the 4th quarter valued at approximately $43,000. 87.43% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

AME has been the subject of several research reports. Mizuho raised their price target on shares of AMETEK from $212.00 to $225.00 and gave the stock an "outperform" rating in a research note on Friday, August 1st. Morgan Stanley raised their target price on shares of AMETEK from $185.00 to $198.00 and gave the company an "equal weight" rating in a research report on Friday, August 8th. TD Cowen raised shares of AMETEK from a "sell" rating to a "hold" rating and boosted their price target for the stock from $158.00 to $180.00 in a research report on Tuesday, September 2nd. Robert W. Baird increased their price objective on shares of AMETEK from $190.00 to $198.00 and gave the stock a "neutral" rating in a research note on Monday, August 4th. Finally, Melius downgraded AMETEK from a "buy" rating to a "hold" rating and set a $192.00 target price on the stock. in a research report on Monday, July 14th. Seven equities research analysts have rated the stock with a Buy rating and six have given a Hold rating to the company's stock. According to data from MarketBeat, AMETEK presently has an average rating of "Moderate Buy" and a consensus price target of $205.45.

AMETEK Stock Down 0.7%

AMETEK stock opened at $187.38 on Wednesday. The company has a debt-to-equity ratio of 0.15, a current ratio of 1.63 and a quick ratio of 1.04. The company's 50-day moving average is $182.87 and its 200-day moving average is $177.07. The firm has a market capitalization of $43.28 billion, a PE ratio of 30.17, a P/E/G ratio of 2.71 and a beta of 1.10. AMETEK, Inc. has a fifty-two week low of $145.02 and a fifty-two week high of $198.33.

AMETEK (NYSE:AME - Get Free Report) last posted its quarterly earnings results on Thursday, July 31st. The technology company reported $1.78 EPS for the quarter, topping analysts' consensus estimates of $1.69 by $0.09. AMETEK had a return on equity of 16.53% and a net margin of 20.60%.The business had revenue of $1.78 billion during the quarter, compared to analysts' expectations of $1.74 billion. During the same quarter last year, the company posted $1.66 earnings per share. AMETEK's quarterly revenue was up 2.5% on a year-over-year basis. AMETEK has set its Q3 2025 guidance at 1.720-1.760 EPS. FY 2025 guidance at 7.060-7.200 EPS. Sell-side analysts anticipate that AMETEK, Inc. will post 7.15 earnings per share for the current year.

AMETEK Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 30th. Shareholders of record on Monday, September 15th will be given a dividend of $0.31 per share. This represents a $1.24 dividend on an annualized basis and a yield of 0.7%. The ex-dividend date of this dividend is Monday, September 15th. AMETEK's payout ratio is 19.97%.

About AMETEK

AMETEK, Inc manufactures and sells electronic instruments and electromechanical devices in the North America, Europe, Asia, and South America, and internationally. The company's EIG segment offers advanced instruments for the process, aerospace, power, and industrial markets; process and analytical instruments for the oil and gas, petrochemical, pharmaceutical, semiconductor, automation, and food and beverage industries; instruments to the laboratory equipment, ultra-precision manufacturing, medical, and test and measurement markets; power quality monitoring and c devices, uninterruptible power supplies, programmable power and electromagnetic compatibility test equipment, and sensors for gas turbines and dashboard instruments; heavy trucks, instrumentation, and controls for the food and beverage industries; and aircraft and engine sensors, power supplies, embedded computing, monitoring, fuel and fluid measurement, and data acquisition systems for aerospace and defense industry.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.